Stay updated on Magrolimab in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page
- Check5 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study page remains a 403 error.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA sitewide NIH banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check33 days agoChange DetectedThe footer now displays an updated ClinicalTrials.gov site revision identifier.SummaryDifference0.2%

- Check40 days agoChange DetectedAccess to the study page now returns a 403 Forbidden error, replacing the expected study content. This indicates a permissions issue rather than an update to the study data or page features.SummaryDifference22%

- Check54 days agoChange DetectedThe page shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a software version update applied to the page.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6. This signals a new release of the ClinicalTrials.gov interface/backend, and the visible study content remains unchanged.SummaryDifference0.0%

Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.